pLN539 (FuGW-G8p-antiPD1(HC)-P2A-antiPD1(LC)-1Pe) Citations (1)
Originally described in: Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy.Nissim L, Wu MR, Pery E, Binder-Nissim A, Suzuki HI, Stupp D, Wehrspaun C, Tabach Y, Sharp PA, Lu TK Cell. 2017 Nov 16;171(5):1138-1150.e15. doi: 10.1016/j.cell.2017.09.049. Epub 2017 Oct 19. PubMed Journal
Articles Citing pLN539 (FuGW-G8p-antiPD1(HC)-P2A-antiPD1(LC)-1Pe)
| Articles |
|---|
| Engineering of alpha-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, Zhang J, Wang G, Verhoeyen E, Zhang Y, Zhang H. Cell Death Dis. 2020 Nov 12;11(11):973. doi: 10.1038/s41419-020-03187-1. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.